Restricted accessResearch articleFirst published online 2001-12
Lessons to be learned: a case study approach A case study of the temporal onset of pulmonary hypertension with pre-existent cirrhotic portal hypertension
We report the occurrence of pulmonary hypertension in a 37-year-old male patient with cirrhosis of the liver, portal hyperten sion and oesophageal varices. Although this is a rare combination, previous reports have shown that the association of portal and pulmonary hypertension is not coinci dental; the temporal onset of primary pul monary hypertension is hard to predict and our patient was asymptomatic for a number of years. The pathogenesis of portal hypertension leading to pulmonary hyper tension is not known. Diagnosis is difficult because the clinico-pathological symptoms in both conditions are similar. Treatment is limited to calcium channel blockers, vasodilators, nitrous oxide and prostacyclin, although most patients will eventually require visceral transplantation.
Dennis C.M., Mcneil K.D., Dunning J., Stewart S., Friend P.J., Alexander G., et al (1996). Heart lung liver transplantion. J Heart Lung Transplant, 15, 536-538
2.
Hadengue A., Benhayoun M.K., Lebrec D. and Benhamou J.P. (1991). Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic haemodynamics. Gastroenterology , 100, 520-528
3.
Hughes J.D. and Rubin L.J. (1986). Primary pulmonary hypertension. An analysis of 28 cases and a review of the literature. Medicine; 65, 56-72
4.
Koneru B., Ahmed S., Weisse A.B., Grant G.P. and Mckim K.A. (1994). Resolution of pulmonary hypertension of cirrhosis after liver transplantation. Transplantation;58, 1133-1135
5.
Levy M.T., Torzillo P., Bookallil M., Sheil A.G. and Mccaughan G.W. (1996). Case report: delayed resolution of severe pulmonary hypertension after isolated liver transplantation in a patient with cirrhosis . J Gastrenterol Hepatol; 11,734-737
6.
Mantz F.A. and Craig E. (1951). Portal axis thrombosis with spontaneous portacaval shunt and resultant cor pulmonale. Arch Pathol; 52, 91
7.
Mcdonnell P.J., Toye P.A. and Hutchins G.M. (1983). Primary pulmonary hypertension and cirrhosis: are they related? Am Rev Respir Dis;127, 437-441
Nakayama Y., Nakanishi N., Sugimachi M., Takaki H., Kyotani S., Satoh T., et al (1997). Characteristics of pulmonary artery pressure waveform for differential diagnosis of chronic pulmonary thromboembolism and primary pulmonary hypertension. J Am Coll Cardiol;29, 1311-1316
10.
Olschewski H., Walmrath D., Scher-Muly R., Ghofrani A., Grimminger F. and Seeger W. (1996). Aerolised prostacyclin and iloprost in severe pulmonary hypertension. Ann Intern Med;124, 820-824
11.
Prager M.C., Cauldwell C.A., Ascher N.L., Robertss J.P. and Wolfe C.L. (1992). Pulmonary hypertension associated with liver disease is not reversible after liver transplantation. Anaesthesiol;77, 375-378
12.
Rich S. ( 1995). Medical treatment of primary pulmonary hypertension: a bridge to transplantation. Am J Cardiol; 75, 63A-66A
13.
Rich S., Kaufmann E. and Levy P.S. (1992). The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med;327, 76-81
14.
Rich S., Kieras K., Hart K., Groves B.M., Stobo J.D. and Brundage B.H. (1986). Antinuclear antibodies in primary pulmonary hypertension . J Am Coll Cardiol;8, 1307-1311
15.
Robalino B.D. and Moodie D.S. (1991). Association between primary pulmonary hypertension and portal hypertension: analysis of its pathophysiology and clinical, laboratory and haemodynamic manifestations. J Am Coll Cardiol;17, 492-498
Schott R., CHaouat A., Launoy A., Pot-Techer T. and Weitzenblum E. (1999). Improvement of pulmonary hypertension after liver transplantation. Chest, 115, 1748-1749
18.
Scott V., De Wolf A., Kang Y., Martin M., Selby R., Fung J., et al (1993). Reversibility of pulmonary hypertension after liver transplantation: a case report. Transplant Proc;25, 1789-1790
19.
Shah H.A., Piris J. and Finlayson N.D. (1995). Primary pulmonary hypertension developing 11 years after a splenorenal shunt for portal hypertension in hepatic cirrhosis. Eur J Gastroenterol Hepatol;7, 283-286
20.
Sitbon O., Drenot F., Denjean A., et al (1995). Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. Am J Respir Crit Care Med;151, 384-389
21.
Woolf D., Voigt M.D., Jaskiewicz K. and Kalla A.A. (1994). Pulmonary hypertension associated with non-cirrhotic portal hypertension in
22.
systemic lupus erythematosus. Postgrad Med J; 70, 41-43
23.
Yanai-Landau H., Amital H., Bar-Dayan Y., Levy Y., Gur H., Lin H.C., et al (1995). Autoimmune aspects of primary pulmonary hypertension. Pathobiol;63, 71-75
24.
Zhang M., Luo B., Chen S.J., Abrams G.A. and Fallon M.B. (1999). Endothelin-1 stimulation of endothelial nitric oxide synthase in the pathogenesis of hepatopulimonary syndrome. Am J Physiol; 277, G944-G952
